Ga naar website
2 known investors
Reyedar develops an AI-powered eye tracking system that detects biomarkers of neurological and visual health conditions such as glaucoma and Parkinson's disease through automated oculomotor testing. The company serves optometry centers, hospitals, clinics, and clinical research centers seeking rapid, non-invasive screening for neurovisual disorders.
Investors · 2
In the news
- Dutch-based Reyedar raises €3M for early detection of neurodegenerative diseases - Silicon Canalssiliconcanals.com · 2023
- Reyedar Raises €3M in Seed Fundingfinsmes.com · 2023
- Reyedar (formerly Reperio Medtech) raises €3 million capital to further develop groundbreaking solution for detecting degenerative diseases - nvnom.comnvnom.com · 2023
- Dutch deep tech start-up Reyedar raises €3 million to commercialise its degenerative disease screening technology - Tech.eutech.eu · 2023